New Data Shows Breast Cancer Index Testing Influences Extended Endocrine Therapy Decisions Hologic, Inc. and its subsidiary Biotheranostics, Inc. have announced new findings from the Breast Cancer Index (BCI) Registry…
Countable Labs Enters Clinical Market With Ancora Oncology Assays Powered by Single-Molecule PCR Technology Countable Labs, a developer of advanced molecular testing technologies, has announced its entry into the clinical…
THE SAGE GROUP Raises PAD Awareness During National PAD Awareness Month Peripheral artery disease (PAD) continues to be underrecognized and undertreated despite its substantial impact on limb health, cardiovascular outcomes…
CAIRDAC Appoints MedTech Executive Raymond W. Cohen as Board Chairman CAIRDAC, SA, a pre-revenue medical technology company developing an autonomous, leadless and self-powered cardiac pacemaker, has appointed Raymond W. Cohen…
Scientific Review Identifies Selenium Sulfide and Zinc Pyrithione as Evidence-Based Dandruff Treatments Scientists from Head & Shoulders and dermatology experts reviewed the latest clinical evidence on dandruff treatment during the…
Exobiosphere and Voyager Expand ISS Missions as Demand for Microgravity Drug Discovery Rises Voyager Technologies (NYSE: VOYG) and Exobiosphere have announced two additional research campaigns aboard the International Space Station…
Genialis and Inventia Life Science Collaborate to Advance Patient-Relevant Pancreatic Cancer Models Genialis, a therapeutic intelligence company, and Inventia Life Science, a developer of advanced 3D cell model technologies, have…
Allotera Therapeutics Opens MRD-Positive Cohort in Pivotal T-RRex Study of Sofi-cel for T-ALL and T-LBL Allotera Therapeutics, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for hematological malignancies,…
ApalyRx and Vida Health Partner to Expand Cost-Effective, Integrated Weight-Loss Care for Employers ApalyRx, a pharmacy technology platform designed to assess prescriptions in real time and route them to the…
Polaris Rx Selected Again as Exclusive U.S. Distributor for FluMist Home for 2026–2027 Flu Season Polaris Rx, a provider of long-term care, specialty and infusion pharmacy solutions, has been selected…
BioIVT to Showcase Translational Research Strategies for Metabolic Disease, GLP-1 Therapies and Emerging Drug Development Models BioIVT, a global research partner and biospecimen solutions provider supporting drug and diagnostic development,…
Pilatus Biosciences to Present Phase 1 PLT012 Clinical Trial at ESMO Congress 2026 Pilatus Biosciences, a biopharmaceutical company focused on developing novel metabolic checkpoint immunotherapies for cancer, announced that its…